Abstract:Stroke seriously threatens human health because of its characteristics of high morbidity, disability, recurrence, and mortality, thus representing a heavy financial and mental burden to affected families and society. Many preclinical effective drugs end in clinical-translation failure. Animal models are an important approach for studying diseases and drug effects, and play a central role in biomedical research. Some details about animal models of cerebral ischemia have not been published, such as left-/right-sided lesions or permanent cerebral ischemia/cerebral ischemia-reperfusion. In this review, ischemia in the left- and right-hemisphere in patients with clinical stroke and preclinical studies were compared for the first time, as were the mechanisms of permanent cerebral ischemia and cerebral ischemia-reperfusion in different phases of the disease. The results showed that stroke in the left hemisphere was more common in clinical patients, and that most patients with stroke failed to achieve successful recanalization. Significant differences were detected between permanent cerebral ischemia and cerebral ischemia-reperfusion models in the early, subacute, and recovery phases. Therefore, it is recommended that, with the exception of the determined experimental purpose or drug mechanism, left-sided permanent cerebral ischemia animal models should be prioritized, as they would be more in line with the clinical scenario and would promote clinical translation. In addition, other details regarding the preoperative management, surgical procedures, and postoperative care of these animals are provided, to help establish a precise, effective, and reproducible model of cerebral ischemia model and establish a reference for researchers in this field.

Overview in Establishing Animal Models Against Ischemic Cerebrocardiac Disease and Thinking about Efficacy Evaluation of Traditional Chinese Medicine

Murine Models of Vascular Endothelial Injury: Techniques and Pathophysiology

Advances in Establishment of Animal Models with Hepatic Cirrhosis and Thinking about Efficacy Evaluation of Traditional Chinese Medicine

Animal models and evaluation methods of ischemic brain injury

Advances in establishments of animal models with MID and thinking about efficacy evaluation of TCM

Animal models of cerebral ischemia: A review

Construction and Evaluation of Animal Models for Cerebral Ischemia

Innovative drug discovery strategy from Traditional Chinese medicine based on the molecular mechanisms of ischemic cerebrovascular disease

Small Mammalian Animal Models of Heart Disease.

Animal Models of Ischemic Heart Disease for in Vivo Cardiac MR Imaging Research

The Animal Model of Combination of Illness and Syndrome is Foundation to Study the Ischemia of Cerebrovascular Disease in TCM

Rodent Models for Intravascular Ischemic Cerebral Infarction: a Review of Influencing Factors and Method Optimization

Reflect on the Methods and Evaluations of Pharmacology and Pharmacodynamics in Alzheimer′ Disease

Cerebral Ischemia Models in Rats

A Series of Methods for Screening and Evaluating Potential Anti-Cardiovascular Drugs from Traditional Chinese Herbs

Advances in Establishments of Animal Models with Kidney-Yang Deficiency Syndrome and Thinking about Efficacy Evaluation of Traditional Chinese Medicine

Advances on Animal Model of Cerebral Ischemia

Large Mammalian Animal Models of Heart Disease

Animal Models for Cardiovascular Research

Current Preparing Situation and Thinking of Stroke Animal Models Combined with Disease and Syndrome

Chronic vasogenic cerebral ischemic animal modeling